JOHN S. SONNIER is a Senior Biotechnology Analyst with the Prudential
Vector Healthcare Group, focusing on small, mid- and large-cap companies
in the areas of infectious disease, transfusion medicine and
neuroscience. He joined Prudential Securities via the July 1999
acquisition of Vector Securities International, Inc. Prior to joining
Vector, Mr. Sonnier spent eight years in the pharmaceutical industry at
Johnson & Johnson and Baxter and, most recently, as the Senior
Healthcare Planning Manager at Baxter Healthcare Corporation, Biotech
Group. He received his BS degree in Business from the University of
Southern Mississippi.
Roundtable Forum: Outlook For Biotechnology
May 29, 2000